<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical management of severe obesity in adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical management of severe obesity in adolescents</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical management of severe obesity in adolescents</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas H Inge, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel Jones, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Melvin B Heyman, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 08, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Severe obesity is a significant health problem facing a large proportion of adults and children in the United States and increasingly worldwide [<a href="#rid1">1-3</a>]. Due to a lack of nonsurgical options for severely obese adolescents and a demonstrated safety and efficacy record in adults, there has been increasing interest in surgical procedures for weight loss ("bariatric surgery") for selected adolescents with severe obesity. There is insufficient evidence bearing on safety or effectiveness to recommend use of surgery for children or preadolescents at this time.</p><p>The rationale, outcomes, and indications for weight loss surgery in adolescents will be reviewed here. The management and outcomes of weight loss surgery in adults and other aspects of obesity in children and adolescents are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/586.html" rel="external">"Bariatric surgery for management of obesity: Indications and preoperative preparation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/88610.html" rel="external">"Bariatric surgery: Postoperative and long-term management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5861.html" rel="external">"Clinical evaluation of the child or adolescent with obesity"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5869.html" rel="external">"Overview of the health consequences of obesity in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15848.html" rel="external">"Prevention and management of childhood obesity in the primary care setting"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">RATIONALE</span><span class="headingEndMark"> — </span>Children and adolescents with severe obesity are at risk for and are developing important comorbidities, including obstructive sleep apnea, diabetes, hypertension, dyslipidemia, nonalcoholic fatty liver disease, and idiopathic intracranial hypertension, as well as depression and impaired quality of life [<a href="#rid4">4-9</a>]. Severe obesity has also been linked to shorter life expectancy [<a href="#rid10">10</a>]; therefore, treatment that is targeted at obesity may reverse or prevent these problems and improve long-term health outcomes [<a href="#rid11">11,12</a>]. (See  <a class="medical medical_review" href="/d/html/5869.html" rel="external">"Overview of the health consequences of obesity in children and adolescents"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">History of weight loss surgery</span><span class="headingEndMark"> — </span>During the past 40 years, weight loss surgery has clearly been shown to produce significant and sustained reductions in body mass index (BMI), diabetes, and hypertriglyceridemia in adults. It also reduces mortality, as highlighted in a 24-year follow-up of patients undergoing Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB), or vertical banded gastroplasty in the Swedish Obese Subjects Study [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/586.html" rel="external">"Bariatric surgery for management of obesity: Indications and preoperative preparation"</a>.)</p><p>Bariatric surgery has also increasingly been used to treat adolescents with severe obesity, and the evidence base supporting use of surgery has accumulated, most notably over the past two decades. In late 2019, the Section on Obesity of the American Academy of Pediatrics (AAP) published a policy statement supporting the use of surgery within the context of a multidisciplinary program with pediatric expertise for treating youth with severe obesity [<a href="#rid14">14</a>]. In addition to providing clinical guidance, the policy statement highlighted concerns about access to care, which represents a barrier to the appropriate use of bariatric surgery among eligible adolescents. In 2023, the AAP published a clinical practice guideline that comprehensively addresses pediatric obesity treatment including recommendations for pharmacotherapy and referral for consideration of weight loss surgery [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Consequences of severe obesity</span><span class="headingEndMark"> — </span>Obesity in children and adolescents is classified by severity, using the following thresholds  (<a class="graphic graphic_figure graphicRef90747 graphicRef91083" href="/d/graphic/90747.html" rel="external">figure 1A-B</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Class I – BMI ≥95<sup>th</sup> percentile for age and sex or BMI ≥30 (whichever is lower).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Class II – BMI ≥120 percent of the 95<sup>th</sup> percentile values <strong>or</strong> a BMI ≥35 kg/m<sup>2</sup> (whichever is lower). This corresponds to approximately the 98<sup>th</sup> percentile.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Class III – BMI ≥140 percent of the 95<sup>th</sup> percentile values <strong>or</strong> a BMI ≥40 kg/m<sup>2</sup>.</p><p></p><p>Severe (class II or III) obesity affects approximately 10 percent of girls and 13 percent of boys 12 to 19 years old in the United States [<a href="#rid15">15</a>]. These children will almost always remain in the obese range as adults, and 65 percent will have class III obesity as adults (BMI ≥40 kg/m<sup>2</sup>) [<a href="#rid16">16,17</a>]. They have a significantly greater prevalence of cardiovascular risk factors compared with children with lesser degrees of obesity and will have more health complications and higher mortality compared with those who developed obesity during adulthood [<a href="#rid18">18-22</a>]. (See  <a class="medical medical_review" href="/d/html/5874.html" rel="external">"Definition, epidemiology, and etiology of obesity in children and adolescents", section on 'Definitions'</a> and  <a class="medical medical_review" href="/d/html/5869.html" rel="external">"Overview of the health consequences of obesity in children and adolescents"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Alternatives to surgery</span><span class="headingEndMark"> — </span>Because of the potential risks of surgical weight loss, noninvasive approaches should always be the first-line treatment for any child or adolescent with obesity. The best established approaches are multidisciplinary, using family-based behavioral techniques to support changes in diet and physical activity, with goals of reducing caloric intake, improving the quality of the food intake, and increasing energy expenditure. Recommendations from the AAP and other professional organizations advocate early intervention with dietary and lifestyle changes for children with excessive weight gain.</p><p>Unfortunately, the limited data available suggest that dietary and behavioral interventions alone rarely achieve significant long-term success for individuals with severe obesity. As examples, adolescents treated with behavioral therapy (eg, those randomized to placebo with behavioral therapy as controls in pharmaceutical studies for weight loss) have typically demonstrated &lt;3 percent weight loss [<a href="#rid23">23,24</a>]. Similarly, in a study from Sweden, the control group of adolescents with severe obesity experienced a 6 percent weight gain over five years of medical management; this is an informative finding given the 90 percent follow-up rate for this group [<a href="#rid25">25</a>].</p><p>An increasing number of drugs are available for the management of obesity in adolescents. Patient selection for pharmacotherapy, available drugs, and data on outcomes are discussed in a separate topic review. (See  <a class="medical medical_review" href="/d/html/15848.html" rel="external">"Prevention and management of childhood obesity in the primary care setting", section on 'Pharmacotherapy'</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">TYPES OF SURGERY</span><span class="headingEndMark"> — </span>The most widely performed procedures in adolescents and adults are the sleeve gastrectomy (SG; &gt;80 percent) and Roux-en-Y gastric bypass (RYGB; &lt;20 percent) [<a href="#rid26">26-28</a>]. Far fewer adjustable gastric banding (AGB; &lt;5 percent) procedures are performed. Details of these procedures and the experience in adults are discussed in a separate topic review (see  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions", section on 'Procedures endorsed by the ASMBS'</a>). Outcomes of these procedures and considerations specific to adolescents are discussed below. (See <a class="local">'Outcomes'</a> below and <a class="local">'Postoperative management'</a> below.)</p><p class="headingAnchor" id="H7607762"><span class="h2">Sleeve gastrectomy</span><span class="headingEndMark"> — </span>The SG (also known as vertical sleeve gastrectomy) is a partial gastrectomy, in which the majority of the greater curvature of the stomach is removed, creating a tubular stomach  (<a class="graphic graphic_figure graphicRef54612" href="/d/graphic/54612.html" rel="external">figure 2</a>). The frequency of this procedure for weight loss surgery has been rapidly increasing, and it accounts for more than 80 percent of bariatric procedures in adolescents [<a href="#rid27">27-31</a>]. It is typically used as a standalone procedure [<a href="#rid32">32</a>]. If patients regain weight in the long term, the SG can be converted to a RYGB, but this is uncommon. Data on very long-term outcomes are pending. (See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions", section on 'Sleeve gastrectomy'</a>.)</p><p>Because SG is less complex than RYGB and has a lower theoretical risk of micronutrient deficiencies, it is an appealing option for adolescents. In a study from the United States with five-year follow-up, SG was associated with reduced frequency of emergency department visits (53.3 versus 59.9 percent) and hospitalization (36.9 versus 52.1 percent) compared with RYGB [<a href="#rid31">31</a>]. There was no significant difference in the frequency of complications (1.5 versus 2.1 percent) or reoperations (7.2 versus 7.7 percent). Outcomes for weight loss and comorbidity improvement are generally excellent, although the long-term weight loss may be less than for RYGB, at least for a subset of patients [<a href="#rid33">33</a>]. Compared with AGB, SG has the advantage of avoiding a foreign body and potential associated complications. (See <a class="local">'Outcomes'</a> below.)</p><p>SG may be a particularly appropriate choice of procedure for individuals with cognitive deficits, younger age, or other issues that might increase risk for postoperative nutritional deficiencies. However, outcomes for these special populations remain unclear because the only information is from very small case series with several years follow-up. (See <a class="local">'Special populations'</a> below.)</p><p class="headingAnchor" id="H415344196"><span class="h2">Roux-en-Y gastric bypass</span><span class="headingEndMark"> — </span>RYGB creates a small (less than 30 mL) proximal gastric pouch that is divided and separated from the distal stomach and anastomosed to a Roux-limb of small bowel 75 to 150 cm in length  (<a class="graphic graphic_figure graphicRef79256" href="/d/graphic/79256.html" rel="external">figure 3</a>). The surgery was the most commonly performed bariatric procedure in the United States until approximately 2012 but now accounts for less than 20 percent of procedures in adolescents. (See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions", section on 'Roux-en-Y gastric bypass'</a>.)</p><p>The long-term outcomes for weight loss and comorbidity improvement are well established for RYGB, based on more than 25 years of experience with this procedure in adults. In addition, it has particularly dramatic benefits on glycemic control, which may offer some advantage for patients with type 2 diabetes [<a href="#rid34">34</a>]. On the other hand, there are probably more risks for nutritional deficiencies compared with SG. In particular, iron sufficiency and long-term outcomes for bone health after RYGB are not well studied. (See  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Diabetes mellitus'</a>.)</p><p class="headingAnchor" id="H415344370"><span class="h2">Adjustable gastric banding</span><span class="headingEndMark"> — </span>AGB is a purely restrictive procedure that compartmentalizes the upper stomach by placing a tight, adjustable prosthetic band around the entrance to the stomach  (<a class="graphic graphic_figure graphicRef57064" href="/d/graphic/57064.html" rel="external">figure 4</a>). The US Food and Drug Administration (FDA) has approved two AGB devices for use in adults in the United States, but these devices are not FDA-approved for adolescents younger than age 18. With increasing use of SG, AGB use has dramatically declined. (See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions", section on 'Laparoscopic adjustable gastric banding'</a>.)</p><p class="headingAnchor" id="H7607776"><span class="h2">Other</span><span class="headingEndMark"> — </span>Endoscopically placed intragastric balloons are approved by the FDA for short-term use (up to six months) in adults with severe obesity but have only been studied in a few single-center, small case series of adolescents. In a two-year cohort study of 12 adolescents with severe obesity, clinically significant, modest improvements in weight (mean 5 percent loss) and some measures of glucose metabolism (insulin area under the curve and glycated hemoglobin) were seen at six months, while the intragastric balloon was in place [<a href="#rid35">35</a>]. However, after device removal, weight loss and cardiometabolic benefits were not sustained for most participants at two-year follow-up. Further, these devices are not approved for use in adolescents by the FDA. (See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions", section on 'Intragastric balloon'</a>.)</p><p>In the past, the range of surgical weight loss procedures performed on adults and a few adolescents included jejunoileal bypass (a procedure associated with a high rate of malabsorptive complications), vertical banded gastroplasty, and banded gastric bypass. Due to unsatisfactory safety profiles and/or efficacy, these procedures are no longer recommended. Other procedures that cause malabsorption, such as biliopancreatic diversion, are occasionally performed on adults but are generally not recommended for adolescents, due to lack of safety data in this age group and concerns about long-term nutritional complications [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions"</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">MECHANISMS OF WEIGHT LOSS</span><span class="headingEndMark"> — </span>Reduction of caloric intake plays an important role in the dramatic weight loss produced by bariatric surgery. However, this is only partially attributable to a reduced capacity of the stomach or pouch. Many patients report a subjective decrease in appetite and increase in postprandial satiety after surgery, which help them maintain lower intakes of food. This experience suggests that the effects of bariatric surgery on weight loss and comorbidities may have neuroendocrine mechanisms and are not entirely attributable to mechanical restriction of food intake or to malabsorption.</p><p>Emerging data suggest that alterations in neuroenteric hormones that regulate appetite and energy expenditure could contribute to changes in satiety after surgery. Several studies have demonstrated an increase in postprandial peptide YY (PYY) concentrations after Roux-en-Y gastric bypass (RYGB) compared with lean or obese nonoperative controls [<a href="#rid37">37,38</a>]. This postprandial increase in PYY is not reported after an adjustable gastric banding (AGB) [<a href="#rid39">39,40</a>]. However, a single series of 12 patients undergoing the vertical banded gastroplasty (also purely restrictive) reported an increase in fasting and postprandial PYY concentrations after surgery to levels comparable with concentrations measured in lean controls [<a href="#rid41">41</a>].</p><p>In addition, bile acid signaling, mediated through the farnesoid X receptor (FXR), appears to be integral to achieving the weight loss and beneficial metabolic effects of sleeve gastrectomy (SG) in rodent models of bariatric surgery [<a href="#rid42">42</a>]. Studies in adults have also demonstrated a rise in circulating total bile acids after RYGB and to a lesser degree after SG; however, no significant change was demonstrated after AGB [<a href="#rid43">43,44</a>]. Bile acids have also been shown to rise significantly in adolescents as well during the rapid weight loss phase in the first three months after SG [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H415345737"><span class="h1">PREOPERATIVE EVALUATION AND SCREENING</span></p><p class="headingAnchor" id="H415345744"><span class="h2">Screening</span><span class="headingEndMark"> — </span>Recommended screening prior to surgical weight loss procedures includes evaluation for the presence and severity of coexisting diseases, as well as assessment of the patient's and family's understanding and readiness for a life-changing and often permanent procedure. Recommended screening tests and evaluations that should be completed during the evaluation are highlighted in the table  (<a class="graphic graphic_table graphicRef55342" href="/d/graphic/55342.html" rel="external">table 1</a>). The final decision on whether to proceed with surgery must be made by the multidisciplinary team, taking into consideration both objective and subjective assessments of the patient's severity of obesity and related diseases, risk of future health problems, failure to lose weight through more conventional means, psychosocial status and support, and patient and family readiness for surgery.</p><p>A multidisciplinary approach is recommended when offering weight loss surgery to adolescents [<a href="#rid46">46-48</a>]. At a minimum, the team evaluating and caring for the candidate should include an experienced bariatric surgeon, pediatric obesity specialist, nurse, dietician, and pediatric psychologist or psychiatrist. One of these providers or an additional team member should have responsibility for coordinating each patient's care and ensuring follow-up and adherence to the prescribed medical regimen. The program also must have ready access to relevant pediatric subspecialties, including endocrinology, cardiology, gastroenterology, pulmonology, gynecology, and orthopedics, for further evaluation and/or management of specific comorbidities as needed.</p><p class="headingAnchor" id="H415345830"><span class="h2">Patient selection</span><span class="headingEndMark"> — </span>For adolescents younger than 18 years of age, the following thresholds are recommended for consideration of weight loss surgery; these reflect percentile-based definitions for severe obesity in youth  (<a class="graphic graphic_figure graphicRef90747 graphicRef91083" href="/d/graphic/90747.html" rel="external">figure 1A-B</a>) [<a href="#rid6">6,8,14,49,50</a>] (see  <a class="medical medical_review" href="/d/html/5874.html" rel="external">"Definition, epidemiology, and etiology of obesity in children and adolescents", section on 'Definitions'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Class II obesity</strong> (BMI ≥120 percent of the 95<sup>th</sup> percentile for BMI for age or BMI ≥35 kg/m<sup>2</sup>, whichever is lower), <strong>with a comorbidity</strong> of obesity that has significant effects on health, including but not limited to type 2 diabetes mellitus, idiopathic intracranial hypertension, obstructive sleep apnea (apnea-hypopnea index &gt;5), nonalcoholic steatohepatitis, Blount disease, slipped capital femoral epiphysis, gastroesophageal reflux disease, arterial hypertension, insulin resistance, or reduced health-related quality of life</p><p></p><p class="bulletIndent1"><strong>or</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Class III obesity</strong> (BMI ≥140 percent of the 95<sup>th</sup> percentile of BMI for age or BMI ≥40 kg/m<sup>2</sup>, whichever is lower), with or without an obesity-related comorbidity</p><p></p><p>In adults, the threshold for consideration of weight loss surgery is a body mass index (BMI) ≥35 kg/m<sup>2</sup>; a threshold of ≥30 kg/m<sup>2</sup> is used for individuals with significant current comorbidities, such as diabetes [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/586.html" rel="external">"Bariatric surgery for management of obesity: Indications and preoperative preparation"</a>.)</p><p>Current guidelines for adolescent bariatric surgery do not recommend limiting access to surgery based on pubertal status or physical maturity, as determined by Tanner stage or bone age. Initially, it was theorized that rapid weight loss might inhibit linear growth; however, this has not been demonstrated. On the contrary, a small study of sleeve gastrectomy (SG) in children younger than 14 years found improved linear growth postoperatively compared with matched controls [<a href="#rid52">52</a>]. (See <a class="local">'Special populations'</a> below.)</p><p>Regarding a history of efforts to lose weight through changes in diet and physical activity, there is no evidence that prolonged preoperative weight management programs enhance selection of patients for weight loss surgery. However, consistent attendance in such a treatment program may be a valuable indicator of the patient's ability to understand and adhere to medical and nutritional recommendations postoperatively.</p><p>These guidelines rest primarily on expert opinion and retrospectively evaluated outcomes data [<a href="#rid6">6</a>]. There is only one randomized controlled trial in adolescents that demonstrates superiority of surgical weight loss (in this case, adjustable gastric banding) compared with conventional medical therapy for the severe comorbidities listed above [<a href="#rid53">53,54</a>]. However, randomized controlled trials in adults with type 2 diabetes mellitus have demonstrated that bariatric surgery (including Roux-en-Y gastric bypass [RYGB], adjustable gastric banding [AGB], and SG) is significantly more effective than conventional or intensive medical therapy in resolution of type 2 diabetes mellitus at one and two years postoperatively [<a href="#rid55">55,56</a>].</p><p>It should be recognized that the above criteria alone are not sufficient to select the patients who are most likely to benefit from weight loss surgery during adolescence. We recommend that the multidisciplinary team consider carefully whether the patient and family have the ability and motivation to adhere to recommended treatments pre- and postoperatively, including consistent use of micronutrient supplements. Evidence may include a history of reliable attendance at office visits for weight management and adherence to other medical guidance. In addition, the team should consider whether the adolescent shows evidence of mature decision-making, with appropriate understanding of the risks and benefits of surgery, and has support but not coercion from family members.</p><p>Although no studies have directly addressed the timing of surgical intervention relative to BMI trends or age (see <a class="local">'Weight loss'</a> below), many experts believe that earlier surgical intervention probably is beneficial for adolescents with progressively worsening obesity (analogous to the surgical approach for cancers). This opinion is based upon indirect evidence from observational studies in adolescents and adults in which lower BMI at baseline generally predicts lower absolute BMI after surgery. Because bariatric surgery results in a loss of 25 to 30 percent of BMI, on average, treatment rendered earlier after the diagnosis of severe obesity is more likely to result in postoperative BMI values that are in the healthier ranges [<a href="#rid57">57</a>]. A study that followed adolescents for five years after weight loss surgery found no difference in weight loss or quality of life in younger patients (13 to 15 years, n = 66) compared with older patients (16 to 19 years, n = 162) [<a href="#rid58">58</a>]. This suggests that intervention at a younger age is effective and that outcomes are more likely mediated by BMI rather than age.</p><p>Regarding comorbidity resolution, there is also compelling evidence that intervening during adolescence, rather than waiting until adulthood, increases the likelihood of remission of cardiovascular risk factors and diabetes, which are known to have a more aggressive course in adolescent patients [<a href="#rid34">34,59-62</a>].</p><p>Contraindications for surgical weight loss procedures in adolescents include:</p><p class="bulletIndent1"><span class="glyph">●</span>Medically correctable cause of obesity</p><p class="bulletIndent1"><span class="glyph">●</span>An ongoing substance abuse problem (within the preceding year)</p><p class="bulletIndent1"><span class="glyph">●</span>A medical, psychiatric, psychosocial, or cognitive condition that prevents adherence to postoperative dietary and medication regimens or impairs decisional capacity</p><p class="bulletIndent1"><span class="glyph">●</span>Current or planned pregnancy within 12 to 18 months of the procedure</p><p class="bulletIndent1"><span class="glyph">●</span>Inability on the part of the patient or parent/guardian to comprehend the risks and benefits of the surgical procedure</p><p></p><p class="headingAnchor" id="H415346073"><span class="h2">Special populations</span><span class="headingEndMark"> — </span>The appropriate use of weight loss surgery for individuals with cognitive deficits or immaturity remains unclear. There is limited evidence that weight loss surgery, and SG in particular, may be safe and beneficial in patients with cognitive deficits, younger age, or other issues. Outcomes of SG for these populations are based on small case series with several years of follow-up.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Syndromic obesity and/or intellectual disability</strong> – In two small case series, adolescents with intellectual disability (but not Prader-Willi syndrome) had similar weight outcomes after SG compared with those without intellectual disability [<a href="#rid63">63,64</a>]. Similarly, two overlapping case series of 226 pediatric patients undergoing SG included seven patients with Prader-Willi syndrome, two with Bardet-Biedl syndrome, three with intellectual disability, and one with Down syndrome [<a href="#rid65">65,66</a>]. There were no deaths and no major complications.</p><p></p><p class="bulletIndent1">One contemporary study reports benefits of a narrow SG for individuals with Prader-Willi syndrome, most with two to five years of follow-up [<a href="#rid67">67</a>]. However, more investigation is required before use of weight loss surgery for patients with Prader-Willi or other syndromes can be widely recommended [<a href="#rid68">68,69</a>]. In particular, it is unclear whether long-term durability of weight loss after SG in individuals with Prader-Willi syndrome will be achieved, and the type and frequency of adverse events is inadequately explored. (See  <a class="medical medical_review" href="/d/html/5864.html" rel="external">"Prader-Willi syndrome: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preadolescent children</strong> – Outcomes of surgery in preadolescent children were reported in a study on a population that included 19 children ages 5 through 8.99 years and 56 children 9 to 12.99 years [<a href="#rid52">52</a>]. Children in both age groups experienced good linear growth during the first few years after weight loss surgery. In addition, the two overlapping case series described above included 74 prepubertal patients (5 to 12.99 years), including eight with intellectual disability [<a href="#rid65">65,66</a>]. However, the data collection and follow-up are insufficient to determine the safety and outcomes of SG in this younger age group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypothalamic obesity</strong> – Hypothalamic obesity is particularly resistant to medical and lifestyle management, and weight control may be further complicated by the necessary hormone replacement. Emerging evidence supports bariatric surgery as a means to achieve meaningful weight loss for this population. A review of data from a hypothalamic obesity registry found that bariatric surgery was superior (median BMI decrease of -8.2 kg/m<sup>2</sup>) compared with lifestyle (median BMI -3.4 kg/m<sup>2</sup>) or pharmacologic (median -2.3 kg/m<sup>2</sup>) interventions [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent1">Retrospective observational studies have noted initial weight loss with AGB, SG, and RYGB procedures in this population; however, RYGB may have more significant and durable weight loss. One study compared long-term weight loss (median two to five years) after SG and RYGB and found that weight loss was superior after RYGB and was comparable with postoperative weight loss in control patients without hypothalamic obesity [<a href="#rid71">71,72</a>]. In a meta-analysis of 21 cases of surgical management for hypothalamic obesity, mean weight loss was -20.9 kg after six months (95% CI -35.4 to -6.3) and -15.1 kg after 12 months (95% CI -31.7 to +1.4) [<a href="#rid73">73</a>]. This meta-analysis also demonstrated superior weight loss with RYGB, with a mean weight loss of -31.0 kg (95% CI -77.5 to +15.5) and -33.7 kg (95% CI -80.7 to +13.3) after 6 and 12 months, respectively.</p><p></p><p class="headingAnchor" id="H15"><span class="h1">PERIOPERATIVE SAFETY</span><span class="headingEndMark"> — </span>To provide for optimum safety of the patient while hospitalized, it is important to ensure that the program also has access to pediatric anesthesiology and radiology consultants who have experience caring for individuals with severe obesity. Specialized equipment, such as computed tomography (CT), magnetic resonance imaging (MRI), and dual-energy x-ray absorptiometry (DXA) scanners, often have weight limitations, which may preclude their use for these patients [<a href="#rid74">74</a>]. Further, basic equipment such as operating tables, stretchers, scales, beds, and toilets that can support extreme weight ranges must be available to ensure safety of the patient and caretakers.</p><p>To prevent the development of venous thromboembolism, we recommend frequent ambulation, starting on postoperative day 0, and the use of compression boots when the patient is not ambulatory. Mechanical and chemoprophylaxis are routinely recommended in the adult guidelines [<a href="#rid75">75</a>]. No formal recommendations exist in the adolescent bariatric population; thus, adoption of adult guidelines for adolescents for chemoprophylaxis with low-molecular weight heparin in the perioperative period is reasonable. (See  <a class="medical medical_review" href="/d/html/88610.html" rel="external">"Bariatric surgery: Postoperative and long-term management", section on 'Venous thromboembolism'</a> and  <a class="medical medical_review" href="/d/html/87686.html" rel="external">"Bariatric operations: Early (fewer than 30 days) morbidity and mortality", section on 'Venous thromboembolism'</a>.)</p><p>Weight loss surgery frequently leads to an abrupt resolution of hypertension and hyperglycemia. Antihypertensive or hypoglycemic medications that were given preoperatively usually can be discontinued after surgery, and the patient should be monitored for his or her response. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Diet and texture progression'</a> and  <a class="medical medical_review" href="/d/html/88610.html" rel="external">"Bariatric surgery: Postoperative and long-term management"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">POSTOPERATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Average inpatient stays range from one to three days for laparoscopic Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) [<a href="#rid76">76,77</a>]. Postoperative management for patients includes strict measurement of intake and output and gradual advancement of diet from nil per os (NPO) to clear liquids to a high-protein liquid diet. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management"</a> and  <a class="medical medical_review" href="/d/html/88610.html" rel="external">"Bariatric surgery: Postoperative and long-term management", section on 'Postoperative care after discharge'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Diet</span><span class="headingEndMark"> — </span>Dietary management after discharge varies with the type of surgery. After RYGB and SG, the patient advances through several stages, from high-protein shakes to gradual introduction of greater volumes and more textured and solid foods [<a href="#rid78">78</a>]. The advancement to regular foods is slow, occurring over the first six months after surgery. For best results, the patient is encouraged to eat three to four small, high-protein meals per day and to avoid high-fat and -carbohydrate foods as these may provoke malabsorptive or dumping side effects. Supplemental fluids are encouraged to avoid dehydration (64 to 92 ounces per day of sugar-free, noncarbonated beverages). Drinks should be sugar-free to avoid dumping syndrome and weight regain through overconsumption of liquid calories. Patients also are advised to avoid drinking during meals to avoid nausea and vomiting. Some patients experience greater degrees of nausea in the first postoperative month after SG as compared with RYGB, requiring addition of antiemetics and antinausea medications. Typically, however, this resolves over time.</p><p>Follow-up visits are typically performed at two weeks postoperatively, then 1, 3, 6, 9, and 12 months after surgery. After that, annual follow-up is recommended for monitoring of anthropometric measurements, nutritional status, residual comorbidities, and general health. Follow-up for adjustable gastric banding (AGB) patients typically is more frequent due to the need for band adjustments. Some patients require visits every four to six weeks during the first one to two years.</p><p>General recommendations for long-term weight maintenance include:</p><p class="bulletIndent1"><span class="glyph">●</span>Drinking 8 to 12 8 ounce servings of sugar-free liquids per day. Some providers encourage the patient to avoid or limit caffeinated or carbonated beverages, based on theoretical concerns that these substances may be detrimental after surgery, although there is little evidence to support this concern.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exercising 30 to 60 minutes daily.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eating protein first at each meal (1 g/kg of ideal body weight).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Three to four portion-controlled meals per day, with minimal snacking between meals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Taking daily vitamin and mineral supplementation.</p><p></p><p>These guidelines may need to be tailored to meet an individual patient's needs if significant weight regain or too much weight loss has occurred.</p><p class="headingAnchor" id="H18"><span class="h2">Nutritional supplements</span><span class="headingEndMark"> — </span>After RYGB or SG procedures, lifelong supplementation with vitamins and minerals is recommended to avoid development of nutritional complications secondary to reduced intake and/or mild malabsorption [<a href="#rid14">14</a>]. Although SG and AGB may be associated with reduced risk for nutritional deficiencies compared with RYGB, long-term data on nutritional outcomes are still lacking. Therefore, the same supplementation is prescribed for all patients regardless of the bariatric procedure. As long-term data on outcomes in adolescents are collected, these initial recommendations may be modified.</p><p>After RYGB, patients should conscientiously adhere to a supplementation regimen because of risks for malabsorption of micronutrients; the recommended doses and preparations vary somewhat among practices and may be adjusted based on laboratory measures.</p><p>We prescribe the following supplements for all patients  (<a class="graphic graphic_table graphicRef80913" href="/d/graphic/80913.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Standard multivitamin with folate and iron, or prenatal vitamin if female (once or twice daily).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">Vitamin B12</a>, 500 micrograms sublingually daily, or 1000 micrograms intramuscularly monthly [<a href="#rid78">78</a>]. In those with satisfactory levels at annual monitoring, a single semiannual dose of 3000 micrograms intramuscularly can be considered.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Calcium, 1200 to 1500 mg daily (measured as elemental calcium), with 800 to 1000 international units of vitamin D.</p><p></p><p>Additional supplementation may be necessary during pregnancy or as indicated by laboratory testing. If postoperative vomiting is severe, vitamin B1 (thiamine) deficiency also can rapidly develop [<a href="#rid79">79</a>]. Vitamin B1 deficiency is particularly important to recognize early as lasting neurologic sequelae can result if rapid replenishment of vitamin B1 is not initiated [<a href="#rid80">80,81</a>]. In the author's program, vitamin B1 supplementation (50 mg orally daily) is provided during the first six months after surgery as a prophylactic measure.</p><p class="headingAnchor" id="H19"><span class="h2">Nutritional monitoring</span><span class="headingEndMark"> — </span>After bariatric surgery, lifelong monitoring of nutritional status is recommended. The following parameters are measured annually:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood cell count with differential.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum iron and ferritin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Red blood cell folate, serum <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a>, and serum homocysteine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum thiamine (vitamin B1).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hepatic panel, including albumin, total protein, serum aminotransferase levels, gamma-glutamyl transpeptidase, and alkaline phosphatase.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Calcium, 25-hydroxyvitamin D, and parathyroid hormone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dual-energy x-ray absorptiometry (DXA) scan to monitor lean and fat-free mass and bone density. This test is optional and may not be needed annually for patients with good nutritional status.</p><p></p><p>Adjustments in nutritional supplements may need to be made if specific deficiencies emerge over time, particularly because many adolescents may be nonadherent or only partially adherent to recommended supplementation. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Postsurgical screening'</a>.)</p><p>In addition, monitoring of postoperative eating behaviors appears to be important. In a sample of 234 adolescents undergoing bariatric surgery, loss-of-control eating was reported by up to 28 percent preoperatively and by significantly fewer (&lt;15 percent) postoperatively [<a href="#rid82">82</a>]. While preoperative loss-of-control eating was not associated with postoperative weight loss outcomes, emergence of loss-of-control eating behaviors at one, two, and three years postoperatively was associated with declines in weight loss efficacy. These findings suggest that loss-of-control eating behaviors could be a modifiable target to preserve early weight loss effects of after bariatric surgery.</p><p class="headingAnchor" id="H20"><span class="h2">Pregnancy prevention</span><span class="headingEndMark"> — </span>Severe obesity can lead to irregular menstruation, anovulation, and infertility. Conversely, surgically induced weight loss leads to resumption of ovulation and renewed fertility for some women [<a href="#rid83">83,84</a>]. In a series of 47 adolescent females who had undergone bariatric surgery during adolescence, a higher-than-expected rate of pregnancy was observed (seven pregnancies, six of which occurred between 10 and 22 months postoperatively) [<a href="#rid85">85</a>]. Although the medical and psychosocial factors contributing to this high rate could not be addressed in this retrospective report, the high rate of pregnancy highlights the importance of addressing contraception and pregnancy prevention in all female adolescents undergoing bariatric surgery.</p><p>Pregnancy should absolutely be avoided for at least 12 to 18 months after surgery due to the rapid weight loss and potential micronutrient deficiencies, which may have adverse effects on the mother and fetus. However, long-term effects of bariatric surgery on fertility and pregnancy outcomes are generally good. (See  <a class="medical medical_review" href="/d/html/411.html" rel="external">"Fertility and pregnancy after bariatric surgery"</a>.)</p><p>The efficacy of oral contraceptives or transdermal contraceptive patches may be compromised in patients with obesity [<a href="#rid86">86-88</a>]. This is a significant concern both pre- and postoperatively as many adolescent patients may still have a postoperative body mass index (BMI) &gt;30 kg/m<sup>2</sup> despite significant weight loss after surgery. The American College of Obstetricians and Gynecologists recommends using nonoral forms of hormonal contraception in women who have undergone malabsorptive bariatric surgery and desire hormonal contraception. Further, use of oral contraception is associated with an increased risk of thromboembolism, which may compound the higher risk associated with obesity.</p><p>Depot <a class="drug drug_pediatric" data-topicid="12577" href="/d/drug information/12577.html" rel="external">medroxyprogesterone acetate</a> is effective in overweight or obese women but has been reported to cause significant weight gain (mean of 4 to 9 kg) in overweight or obese adolescents [<a href="#rid89">89,90</a>]. In contrast, the <a class="drug drug_general" data-topicid="104542" href="/d/drug information/104542.html" rel="external">levonorgestrel</a> intrauterine system (Mirena) does not cause weight gain and remains effective in overweight/obese women [<a href="#rid91">91</a>]. It has several notable advantages that make it an optimal choice for adolescent females after bariatric surgery, including five-year efficacy, promotion of amenorrhea (which could help reduce risk of iron deficiency anemia after surgery), and option for placement at time of bariatric surgery [<a href="#rid92">92</a>]. However, as with all forms of hormonal contraception, adolescents should be counseled to use additional barrier protection against sexually transmitted diseases. These and other considerations about contraceptive choice are discussed separately. (See  <a class="medical medical_review" href="/d/html/411.html" rel="external">"Fertility and pregnancy after bariatric surgery"</a>.)</p><p>Adolescent females who become pregnant after weight loss surgery should be counseled about adequate macro- and micronutrient intake. At a minimum, a prenatal vitamin with <a class="drug drug_pediatric" data-topicid="13322" href="/d/drug information/13322.html" rel="external">folic acid</a> and iron, 1200 to 1500 mg of <a class="drug drug_pediatric" data-topicid="12867" href="/d/drug information/12867.html" rel="external">calcium citrate</a> with 800 international units vitamin D, and 500 mcg of oral <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> daily should be prescribed [<a href="#rid93">93</a>]. Additional iron supplementation may be necessary in pregnant women after RYGB. Iron, folate, and vitamin B12 levels should be monitored during pregnancy and additional supplementation prescribed as indicated by results. Protein intake of at least 1 g/kg of ideal body weight (typically 60 to 80 g) per day is recommended.</p><p class="headingAnchor" id="H626283253"><span class="h2">Other risks</span><span class="headingEndMark"> — </span>Adolescents undergoing bariatric surgical treatment may also be at increased risk for psychosocial challenges including suicide and substance abuse disorders. While a prior history of psychopathology does not appear to impact the efficacy of weight loss [<a href="#rid94">94</a>], those with preexisting mental health problems should be considered an at-risk group and may have more difficulties with compliance with postoperative treatment recommendations and, thus, may benefit from more frequent clinical monitoring and anticipatory guidance.</p><p>Regarding suicide in particular, adult bariatric patients appear to have higher rates of suicidal thoughts and behaviors [<a href="#rid95">95</a>] (see  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Psychosocial impact'</a>). Very few studies have explored suicidal behaviors in adolescents undergoing bariatric surgery, but at the time of preoperative assessment, a prior history of suicidal ideation or attempt was reported in 40 and 15 percent, respectively [<a href="#rid96">96</a>]. Following gastric bypass, 14 percent of adolescents participating in a Swedish study reported suicidal ideation at two years postoperatively [<a href="#rid97">97</a>]. In the Teen-LABS study (Longitudinal Assessment of Bariatric Surgery), 16 percent of participants reported suicidal thoughts and behaviors (STB) after surgery, compared with 18 percent in a group of severely obese adolescents who did not undergo surgical weight loss [<a href="#rid98">98</a>]. Predictors or correlates of postoperative STBs were related to prior psychopathology, victimization, and drug/alcohol use and not to surgery-specific factors such as magnitude of weight loss or weight loss satisfaction. Suicide risk reduction is a public health priority for adolescents and young adults. While use of bariatric surgery in adolescence does not appear to increase (or lessen) the risk of engaging in post-surgery STBs, these risks are found in a subgroup of adolescents with poorer psychosocial health. Adolescents with a history of depression and/or past history of suicidal behaviors should be followed closely.</p><p>Experimentation with alcohol and illicit substances is common in adolescents, with almost one-half of students reporting experience with use of an illicit substance by the 12<sup>th</sup> grade [<a href="#rid99">99</a>]. Regarding alcohol and substance use, adolescents undergoing bariatric surgery report lower rates of consumption than national base rates [<a href="#rid100">100</a>]. Nevertheless, the impact of altered anatomy and metabolism on elevating blood concentrations of alcohol after ingestion in a population at risk for substance use suggests that this is an important area for future research and clinical monitoring. (See  <a class="medical medical_review" href="/d/html/7805.html" rel="external">"Identification and management of unhealthy alcohol use in the perioperative period", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H760497490"><span class="h2">Comorbidity reassessment</span><span class="headingEndMark"> — </span>Annual monitoring of cardiometabolic outcomes is recommended by obtaining the following labs and reassessing for recurrent or ongoing symptoms of sleep apnea or other preexisting comorbid conditions.</p><p class="bulletIndent1"><span class="glyph">●</span>Lipid panel</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoglobin A1c</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatic panel</p><p class="bulletIndent1"><span class="glyph">●</span>Cystatin C, creatinine</p><p class="bulletIndent1"><span class="glyph">●</span>Erythrocyte sedimentation rate</p><p></p><p class="headingAnchor" id="H415346736"><span class="h1">OUTCOMES</span></p><p class="headingAnchor" id="H415346843"><span class="h2">Weight loss</span><span class="headingEndMark"> — </span>Both sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in adolescents lead to clinically important decreases in weight and body mass index (BMI) in the majority of patients in the short to intermediate term (one to three years postoperatively). Information about long-term outcomes (longer than three years) is more limited, but the weight loss appears to be sustained, though attrition over time could bias findings.</p><p>The largest prospective study of outcomes of weight loss surgery in adolescents included 242 adolescents with severe obesity who predominantly underwent SG or RYGB at five centers in the United States with special expertise in bariatric surgery for this age group (Teen-LABS study) [<a href="#rid101">101</a>]. The mean age of the participants was 17±1.6 years, and one-third were between 13 and 15 years of age. Among 67 participants undergoing SG, BMI decreased from 50 kg/m<sup>2</sup> at baseline to 37 kg/m2 (a 26 percent reduction) three years postoperatively. Among 161 participants undergoing RYGB, BMI decreased from 54 kg/m<sup>2</sup> at baseline to 39 kg/m<sup>2</sup> (a 28 percent reduction) three years postoperatively  (<a class="graphic graphic_figure graphicRef105660" href="/d/graphic/105660.html" rel="external">figure 5</a>). At three years, weight regain to above baseline occurred in only 4 percent of participants with SG and 2 percent of those with RYGB.</p><p>Longer-term outcomes were reported in a population from one of the Teen-LABS centers, which reported outcomes for 58 individuals undergoing RYGB with more than five years follow-up (FABS-5+ study) [<a href="#rid57">57</a>]. At mean follow-up of eight years, BMI had decreased from 58.5 to 41.7 kg/m<sup>2</sup>, representing a 29.2 percent decrease from baseline but a modest increase from the average nadir BMI one year postoperatively. At long-term follow-up, 63 percent had at least moderately severe obesity (BMI ≥35 kg/m<sup>2</sup>). A separate study from Sweden described long-term outcomes after RYGB in a group of 81 adolescents with less severe obesity [<a href="#rid25">25</a>]. Prior to surgery, the mean BMI was 45.5 kg/m<sup>2</sup>; at follow-up five years postoperatively, the mean BMI was 32.3 kg/m<sup>2</sup> and 28 percent had BMI ≥35 kg/m<sup>2</sup>. In a small randomized trial (50 participants age 13 to 16 years, mean BMI 42.6 kg/m<sup>2</sup> at baseline), RYGB or SG was substantially more effective over two years compared with intensive nonsurgical therapy (difference in mean BMI -12.4 kg/m<sup>2</sup> [95% CI -15.5 to -9.3]) [<a href="#rid102">102</a>]. Together, these studies suggest that surgical intervention in patients with moderate obesity has better absolute BMI outcomes than for patients with severe obesity, supporting the notion that early intervention may be beneficial.</p><p>Previous studies reporting outcomes of weight loss surgery in adolescents have utilized a retrospective design and report short- to intermediate-term outcomes (outcomes measured from 1 to 6.3 years after surgery). A few studies have reported small numbers of patients 10 or more years after their procedure. In most of these long-term studies, a substantial number of subjects were lost to follow-up, which could bias findings.</p><p>Despite these limitations, these studies confirm that clinically significant and durable weight loss can be achieved in most patients by either SG [<a href="#rid65">65,66,103</a>] or RYGB [<a href="#rid104">104-108</a>], while adjustable gastric banding (AGB) is probably somewhat less effective, with slower and less weight loss [<a href="#rid53">53,108-115</a>]. As an example, a meta-analysis of 37 studies reported substantial weight loss with any of these procedures. Mean BMI loss was 16.6 kg/m<sup>2</sup> for RYGB, 14.1 kg/m<sup>2</sup> for SG, and 11.6 kg/m<sup>2 </sup>for AGB; these differences were not statistically significant, and comparison of outcomes was limited by lack of randomization among the procedures and different lengths of follow-up [<a href="#rid33">33</a>]. A subsequent analysis of adolescents undergoing bariatric procedures at health systems affiliated with 11 clinical data research networks in the United States from 2005 to 2015 confirmed these estimates. The cohort included a total of 544 individuals undergoing bariatric surgery (306 SG, 177 RYGB, and 61 AGB) [<a href="#rid29">29</a>]. SG represented only 13 percent of cases from 2005 to 2009 and increased to 83 percent of cases from 2014 to 2015. At one year postoperatively, estimated mean BMI changes were -31 percent for RYGB, -28 percent for SG, and -10 percent for AGB. By three years postoperatively, estimated mean BMI changes were -29 percent for RYGB and -25 percent for SG. Thus, in this study, adolescents undergoing RYGB and SG experienced similar declines in BMI, while AGB was significantly less effective.</p><p>Of note, the nadir postoperative BMI tends to be lower in patients with less severe obesity preoperatively as compared with those with more severe obesity, although the percent BMI change is similar [<a href="#rid116">116</a>]. In a large series of patients from a single center undergoing RYGB, the mean nadir postoperative BMI was 31, 38, and 47 kg/m<sup>2</sup> for patients with starting BMIs between 40 to 54, 55 to 65, and &gt;65 kg/m<sup>2</sup>, respectively [<a href="#rid117">117</a>].</p><p>It is not clear to what degree weight loss will be sustained in adolescents and whether comorbid conditions will recur if significant weight is regained in long-term follow-up. Two studies with 4 to 10 years of follow-up suggest that 10 to 15 percent of patients regain significant weight after RYGB procedures [<a href="#rid104">104,118</a>]. Specific predictors of weight regain after surgical weight loss procedures are unknown for adults and adolescents. Some long-term retrospective studies and meta-analyses have suggested a weight loss advantage comparing RYGB with SG; however, there is still insufficient information to directly compare the long-term weight loss outcomes of SG with those for RYGB or AGB in adolescents [<a href="#rid29">29,33,115,119-122</a>].</p><p class="headingAnchor" id="H415347550"><span class="h2">Comorbidity improvement</span><span class="headingEndMark"> — </span>Weight loss surgery results in resolution of or improvement in most obesity-related diseases in both adults and adolescents. The most dramatic improvements have been seen in insulin resistance, triglyceride levels, type 2 diabetes, elevated blood pressure, obstructive sleep apnea, nonalcoholic fatty liver disease, renal function, male hypogonadism, as well as depression and quality of life [<a href="#rid34">34,57,109,113,123-133</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic and cardiovascular outcomes</strong> – In the Teen-LABS study described above, type 2 diabetes resolved by three years postoperatively in 95 percent of the participants who had the condition at baseline and other comorbidities also resolved in most patients, including prediabetes, elevated blood pressure, and dyslipidemia  (<a class="graphic graphic_figure graphicRef106065" href="/d/graphic/106065.html" rel="external">figure 6</a>) [<a href="#rid101">101,132</a>]. Cardiovascular risk factor resolution was associated with increased weight loss, female sex, and younger age at the time of bariatric surgery [<a href="#rid132">132</a>]. Similar improvements were seen in two studies with more than five-year outcomes, demonstrating long-term durability of these important metabolic effects of surgery [<a href="#rid25">25,57</a>]. The metabolic improvements are consistent with the observation that weight loss after surgery is accompanied by a significant reduction in body fat (from 51 to 37 percent in one series) with relative preservation of lean body mass [<a href="#rid134">134</a>]. Another study showed improvements in obesity-associated cardiac abnormalities, including concentric left ventricular hypertrophy and diastolic function, as measured by echocardiogram performed before and approximately 10 months after RYGB surgery [<a href="#rid135">135</a>].</p><p></p><p class="bulletIndent1">Outcomes of RYGB in adolescents (n = 161) were directly compared with those of adults (n = 396) in a secondary analysis of data from two large National Institutes of Health-funded consortia [<a href="#rid136">136</a>]. There were no significant differences between adolescents and adults in percent weight loss at five years (-26 versus -29 percent, respectively; p = 0.08). However, after surgery, adolescents were significantly more likely than adults to experience remission of type 2 diabetes (86 versus 53 percent; risk ratio [RR] 1.27, 95% CI 1.03-1.57) and remission of hypertension (68 versus 41 percent; RR 1.51, 95% CI 1.21-1.88).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renal function</strong> – Another Teen-LABS analysis highlighted kidney function, a seldom reported outcome after bariatric surgery. Among severely obese adolescents with impaired kidney function at baseline (estimated glomerular filtration rate [eGFR] &lt;90 mL/min/1.73 m<sup>2</sup>), mean eGFR improved from 76 mL/min/1.73 m<sup>2</sup> to 102 mL/min/1.73 m<sup>2 </sup>at three years follow-up (p&lt;0.0001) [<a href="#rid137">137</a>]. Similarly, participants with evidence of kidney injury (albuminuria) at baseline demonstrated a significant improvement of albumin-to-creatinine ratio (ACR); geometric mean of ACR was 74 mg/g at baseline and decreased to 17 mg/g at three years (p&lt;0.0001). Those with normal renal function and no albuminuria at baseline remained stable throughout the study period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Functional mobility</strong> – In the Teen-LABS cohort evaluated three years postoperatively, there were substantial improvements in functional mobility, as demonstrated by a 400-meter walk test, and in musculoskeletal pain [<a href="#rid138">138,139</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychosocial outcomes</strong> – Bariatric surgery leads to improvements in psychosocial functioning, but the improvements are often transient. In the Teen-LABS study, quality of life improved substantially after weight loss surgery [<a href="#rid101">101,139</a>]. A study of 37 adolescents undergoing RYGB showed that anxiety and depression symptoms were higher at baseline than sex-specific norms but declined significantly by four months after surgery [<a href="#rid140">140</a>]. There was no change in anger and disruptive behavior symptoms. In another study of 16 adolescents undergoing RYGB, a substantial reduction in depressive symptoms occurred over the first postoperative year, accompanied by improvements in measures of health-related quality of life and self-concept (social, appearance, and close friendship) [<a href="#rid141">141</a>]. However, these improvements decelerated in the second postoperative year, accompanied by modest weight regain and slight increase in depressive symptoms, as well as declines in measures of health related to quality of life, including social, body esteem, physical comfort, and total domains, as well as self-concept. At two years postoperatively, approximately one-half of the patients with baseline psychopathology continued to experience symptoms [<a href="#rid142">142</a>]. These observations underscore the importance of long-term psychosocial monitoring after surgery. (See <a class="local">'Other risks'</a> above.)</p><p></p><p class="headingAnchor" id="H415347834"><span class="h2">Short-term complications</span><span class="headingEndMark"> — </span>Short-term complications (&lt;30 days after surgery) are generally similar to those in adults and occur in 6 to 8 percent of individuals [<a href="#rid27">27,143</a>]. Complications after RYGB include intestinal leakage at anastomotic sites, wound infections, pulmonary embolus, gastrojejunal strictures requiring endoscopic dilatation, small bowel obstruction, gastrogastric fistula formation, and symptomatic cholelithiasis [<a href="#rid105">105</a>]. Complications of SG also include leak at the staple line. SG patients also may experience heightened and more protracted nausea in the first month postoperatively compared with patients undergoing RYGB. Complications of AGB procedures in adolescents and adults include band slippage requiring repositioning, gastric obstruction, and esophageal or gastric pouch dilatation [<a href="#rid111">111</a>].</p><p>Among the 242 participants in the Teen-LABS study cited above, there were 20 major complications within 30 days of surgery (8 percent overall; RYGB 9 percent, SG 5 percent, and AGB 7 percent) [<a href="#rid27">27</a>]. Major complications included reoperation for bowel obstruction/bleeding leak or sepsis, postoperative bleeding requiring transfusion, or intraoperative splenic injury. There were 47 minor complications (15 percent overall; RYGB 17 percent, SG 12 percent, and AGB 7 percent). Most major and minor complications occurred prior to discharge from the hospital, and there were no deaths. Similarly, reports from other registries indicate that short-term complications appear to be somewhat lower for patients undergoing SG as compared with those undergoing RYGB [<a href="#rid30">30</a>]. Although AGB appears to offer a short-term advantage in complication rates, the procedure also is associated with greater long-term risks for revisional surgery, as described below. (See <a class="local">'Long-term complications'</a> below.)</p><p>Several studies performed in the United States suggest weight loss surgery may be somewhat safer in adolescents as compared with adults [<a href="#rid36">36</a>]. The reason for this is unknown, but the observation may reflect a better state of health among individuals undergoing surgery at a young age.</p><p class="bulletIndent1"><span class="glyph">●</span>A national analysis of weight loss surgery using utilization codes revealed no perioperative mortality and a significantly shorter length of stay in adolescents as compared with adults [<a href="#rid144">144</a>]. Five percent of adolescent patients had major complications, but the majority (78.3 percent) were respiratory in nature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A large study comparing the perioperative outcomes of weight loss surgery between 309 adolescents and 55,192 adults (&gt;18 years) found that the overall 30-day complication rate was significantly lower in adolescents (5.5 percent) as compared with adults (9.8 percent). There was no difference in observed:expected mortality ratios. The 30-day morbidity and mortality rates for adolescents following restrictive procedures (AGB and vertical banded gastroplasty) were nil, compared with the morbidity rate of 4.3 percent for laparoscopic RYGB and 7.6 percent for open RYGB [<a href="#rid145">145</a>].</p><p></p><p class="headingAnchor" id="H415347949"><span class="h2">Long-term complications</span></p><p class="headingAnchor" id="H1179551010"><span class="h3">Nutritional complications</span><span class="headingEndMark"> — </span>Long-term complications of weight loss surgery in adolescents are primarily nutritional. In particular, patients are at risk for deficiencies of iron, <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a>, vitamin D, and thiamine (vitamin B1). These risks are generally higher for RYBG compared with SG. This was shown in five-year outcomes for the Teen-LABS study [<a href="#rid146">146</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Iron deficiency – Prevalence of low serum ferritin increased (71 percent for RYGB; 45 percent for SG).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">Vitamin B12</a> – Prevalence of low vitamin B12 concentrations increased to approximately 12 percent after either procedure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vitamin D and parathyroid hormone – Approximately 40 percent of participants had suboptimal serum 25-hydroxyvitamin D concentrations (&lt;20 ng/mL) at baseline, with no significant change during postoperative follow-up. However, parathyroid hormone concentrations significantly increased during follow-up and the risk of abnormal parathyroid hormone was nearly sixfold higher after RYGB compared with SG. Elevated parathyroid hormone is a marker for functional vitamin D deficiency and raises concern about long-term bone health.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thiamine – Functional thiamine status (erythrocyte transketolase activity) was normal for most patients throughout this study. However, multiple case reports describe acute symptomatic thiamine deficiency in some patients after RYGB [<a href="#rid79">79,80</a>].</p><p></p><p>The risk for these deficiencies decreased with adherence to micronutrient supplements and increased with pregnancy [<a href="#rid146">146</a>]. These findings extend those from earlier studies of an overlapping cohort [<a href="#rid57">57,101</a>] and confirm the increased risk for RYGB compared with SG.</p><p>Because these nutritional deficiencies are common after weight loss surgery, lifelong vitamin and mineral supplementation is imperative. However, adherence to supplementation regimens among adolescents may be poor; one study reported that only 13 percent of adolescents were adherent to all prescribed nutritional supplementation [<a href="#rid104">104,118</a>]. The specific recommendations are outlined above. (See <a class="local">'Nutritional supplements'</a> above.)</p><p>RYGB is associated with reduced bone mass and increased fracture risk in adults and is probably caused by a combination of reduced mechanical load, changes in adipogenic hormones, and nutritional deficiencies [<a href="#rid147">147,148</a>]. In adolescents, reduced bone mass has been noted two years after weight loss surgery but remains appropriate for the individual's age and new body weight [<a href="#rid149">149-151</a>]. However, a study that used advanced quantitative bone imaging in young adults undergoing sleeve gastrectomy found decreased bone strength and increased bone marrow adipose tissue in the lumbar spine two years later [<a href="#rid152">152</a>]. Long-term studies are few, and the clinical implications of these changes are unclear. However, these findings underscore the importance of measures to optimize bone health after weight loss surgery, including supplementing and monitoring vitamin D and calcium and encouraging weight-bearing exercise [<a href="#rid153">153</a>]. (See <a class="local">'Nutritional supplements'</a> above and <a class="local">'Nutritional monitoring'</a> above.)</p><p class="headingAnchor" id="H3380721982"><span class="h3">Other complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postprandial hypoglycemia</strong> – Recurrent episodes of severe postprandial hypoglycemia may develop after RYGB and SG in some adult patients [<a href="#rid154">154-156</a>]. The mechanism of these hypoglycemic episodes is not known but may result in part from increased incretin secretion after surgery, pancreatic islet cell hyperplasia, and inappropriate postprandial hyperinsulinemia [<a href="#rid157">157,158</a>]. Although a similar syndrome in adolescents after RYGB has not yet been reported in the literature, at least one adolescent patient in the authors' weight loss surgery program developed severe postprandial hyperinsulinemia after RYGB. Dietary management by providing small meals with relatively low content of carbohydrates was successful in controlling symptoms. Therefore, it is important to ask adolescents about symptoms that may suggest postprandial hypoglycemia during follow-up care after weight loss surgery. (See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Postprandial hyperinsulinemic hypoglycemia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cholelithiasis</strong> – Cholelithiasis is a common complication of any type of weight loss surgery. In the Teen-LABS study, cholecystectomy was required within three years in 8.6 percent of patients (9.9 percent for RYGB and 5.1 percent for SG) [<a href="#rid101">101</a>]. An additional 5 percent of participants required other abdominal operations, including lysis of adhesions, gastrostomy, or ventral or internal hernia repair. In a study that compared adult with adolescent outcomes of RYGB, abdominal reoperations were more commonly seen in adolescents (20 percent of adolescents versus 16 percent of adults) and cholecystectomy was the most common single intraabdominal reoperation, performed in 14 percent of adolescents and 11 percent of adults after RYGB. However, over 10 times more adults than adolescents had previously undergone cholecystectomy prior to RYGB, suggesting a difference between the proportion of adolescents and adults at risk for postoperative cholecystectomy in this study [<a href="#rid136">136</a>]. (See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Cholelithiasis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastroesophageal reflux</strong> – Symptoms of gastroesophageal reflux, nausea, bloating, and diarrhea significantly increased from six months to five years of follow-up in the Teen-LABS participants, as assessed by a validated gastrointestinal symptom rating scale administered at all postoperative study visits [<a href="#rid159">159</a>]. During five years of follow-up, the incidence of gastroesophageal symptoms gradually increased in both groups, rising from 11 to 24 percent in patients who had undergone SG compared with an increase from 2 to 8 percent among those who had undergone RYGB. At five years postoperatively, the SG group had a more than fourfold greater odds of having these symptoms compared with the RGYB recipients (adjusted odds ratio [OR] 4.85, 95% CI 2.63-8.91). Interestingly, usage of antireflux medications was lower among SG recipients (10 percent) than RYGB participants (14 percent) at five years. Although the prevalence of esophageal inflammation and injury among adolescent recipients of bariatric surgery is not known, based on concerns for possible heightened risk of Barrett esophagus after SG in adults, we recommend assessment for gastroesophageal reflux disease and treatment in all patients reporting significant reflux and heartburn symptoms. (See  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Gastroesophageal reflux disease'</a> and  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Acid reflux or Barrett esophagus'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alcohol use disorder</strong> – At eight years following weight loss surgery, nearly one-half of those who underwent surgery as adolescents screened positively for alcohol use disorder, symptoms of alcohol-related harm, or alcohol-related problems. These findings highlight risk for harmful alcohol use after weight loss surgery in adolescents and provides a rationale for alcohol use disorder evaluation and treatment during follow-up for adolescents undergoing this procedure [<a href="#rid160">160</a>]. (See  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Alcohol and other substance abuses'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Revisional surgery</strong> – In adults who have undergone SG procedures, conversion to RYGB is not uncommon. Indeed, in 2020 to 2021, 86 percent of RYGB procedures were primary cases (no prior surgery) and 14 percent were "secondary" RYGB procedures (performed to convert an SG to RYGB) [<a href="#rid161">161</a>]. The most common reasons for such a conversion include severe gastroesophageal reflux (55 percent of cases) and weight regain (24 percent). (See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions", section on 'Primarily revisional procedures'</a>.)</p><p></p><p>Further details on late complications are provided separately. (See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations"</a>.)</p><p class="headingAnchor" id="H3140288855"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112687.html" rel="external">"Society guideline links: Bariatric surgery"</a> and  <a class="medical medical_society_guidelines" href="/d/html/111346.html" rel="external">"Society guideline links: Obesity in children"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition of severe obesity</strong> – In adolescents, class II obesity is defined as a body mass index (BMI) that is either ≥120 percent of the 95<sup>th</sup> percentile or ≥35 kg/m<sup>2</sup> (whichever is lower)  (<a class="graphic graphic_figure graphicRef90747 graphicRef91083" href="/d/graphic/90747.html" rel="external">figure 1A-B</a>). This threshold corresponds to approximately the 99<sup>th</sup> percentile (Z-score 2.33). Class III obesity is defined as BMI ≥40 kg/m<sup>2</sup> or ≥140 percent of the 95<sup>th</sup> percentile of BMI for age (whichever is lower). (See <a class="local">'Consequences of severe obesity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types of surgery</strong> – The most widely performed procedures in adolescents and adults are the sleeve gastrectomy (SG)  (<a class="graphic graphic_figure graphicRef54612" href="/d/graphic/54612.html" rel="external">figure 2</a>) and Roux-en-Y gastric bypass (RYGB)  (<a class="graphic graphic_figure graphicRef79256" href="/d/graphic/79256.html" rel="external">figure 3</a>). Other procedures that cause significant malabsorption are generally not recommended for adolescents, due to lack of safety data in this age group and concerns about long-term nutritional complications. Adjustable gastric banding (AGB) is rarely used due to suboptimal weight loss for many patients and increasing use of SG. (See <a class="local">'Types of surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative evaluation and screening</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Setting</strong> – Weight loss surgery for adolescents should be performed in the context of a multidisciplinary program with extensive expertise in bariatric surgery and specific expertise in adolescent medicine. (See <a class="local">'Screening'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patient selection</strong> – For adolescents less than 18 years of age, the following BMI thresholds are used for consideration of weight loss surgery  (<a class="graphic graphic_figure graphicRef90747 graphicRef91083" href="/d/graphic/90747.html" rel="external">figure 1A-B</a>):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Class II obesity (BMI of ≥35 kg/m<sup>2</sup> or ≥120 percent of the 95<sup>th</sup> percentile of BMI for age) <strong>with</strong> clinically significant medical comorbidities (ie, those that carry a high risk of morbidity over the short term)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Class III obesity (BMI of ≥40 kg/m<sup>2</sup> or ≥140 percent of the 95<sup>th</sup> percentile of BMI for age), with or without obesity-related comorbidities or impaired quality of life (based on self-report)</p><p></p><p class="bulletIndent2">After 18 years of age, BMI thresholds are the same as those used for adults. Note that a BMI ≥40 kg/m<sup>2</sup> represents very severe obesity in younger patients, particularly those younger than 16 years, in whom this threshold is substantially higher than the 120 percent of the 95<sup>th</sup> BMI percentile curve for age. (See <a class="local">'Patient selection'</a> above.)</p><p></p><p class="bulletIndent2">Other criteria for patient selection include lack of medically correctable causes of obesity, adequate emotional maturity and stability to ensure competent decision-making, and good adherence to medical follow-up  (<a class="graphic graphic_table graphicRef55342" href="/d/graphic/55342.html" rel="external">table 1</a>). In addition, most authorities agree that the patient should have failed organized and attempts to lose weight through lifestyle intervention. (See <a class="local">'Patient selection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Perioperative management</strong> – Perioperative and postoperative management in adolescents is similar to that for adults undergoing weight loss surgery. Diet recommendations vary depending on the type of procedure and vary slightly among centers. (See <a class="local">'Perioperative safety'</a> above and <a class="local">'Diet'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nutritional supplements</strong> – For all patients who have undergone RYGB and SG, we suggest treatment with a daily multivitamin, with additional supplements of calcium, <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a>, and vitamin D  (<a class="graphic graphic_table graphicRef80913" href="/d/graphic/80913.html" rel="external">table 2</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). We perform laboratory monitoring for micronutrient deficiencies at least once annually thereafter. (See <a class="local">'Nutritional supplements'</a> above and <a class="local">'Nutritional monitoring'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pregnancy prevention</strong> – We recommend avoidance of pregnancy for 12 to 18 months after surgical weight loss procedures (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). Because adolescent females appear to be at high risk for pregnancy after bariatric surgery as compared with others in their age group, all females should have counseling about pregnancy avoidance and assurance of adequate contraception as part of the preparation and follow-up after weight loss surgery. (See <a class="local">'Pregnancy prevention'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Weight loss</strong> – Weight loss surgery in adolescents results in loss of between 52 to 70 percent of excess body weight. Weight loss outcomes at three years postoperatively are comparable between SG and RYGB in adolescents  (<a class="graphic graphic_figure graphicRef105660" href="/d/graphic/105660.html" rel="external">figure 5</a>). Emerging data show potential advantages of earlier surgery and good safety outcomes compared with adults. (See <a class="local">'Weight loss'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Effects on comorbidities</strong> – Weight loss surgery results in resolution or substantial improvement in comorbidities  (<a class="graphic graphic_figure graphicRef106065" href="/d/graphic/106065.html" rel="external">figure 6</a>). This includes improvements in insulin resistance, diabetes, obstructive sleep apnea, triglyceride levels, hypertension, kidney function, depression, and quality of life. (See <a class="local">'Outcomes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complications</strong> – Perioperative complications in adolescents undergoing weight loss surgery are generally similar to those in adults but occur somewhat less frequently. Long-term complications are primarily nutritional and include deficiencies of iron, <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a>, vitamin D, and thiamine. Lifelong vitamin and mineral supplementation is imperative. However, adolescents often have poor adherence to supplementation regimens. Other complications include risks for hypoglycemia, cholelithiasis, alcohol use disorder, and decreased bone strength. (See <a class="local">'Outcomes'</a> above.)</p><p></p><p class="headingAnchor" id="H1963452901"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Stavra A Xanthakos, MD, MS, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016; 387:1377.</a></li><li><a class="nounderline abstract_t">QuickStats: Prevalence of Obesity* and Severe Obesity† Among Persons Aged 2-19 Years - National Health and Nutrition Examination Survey, 1999-2000 through 2017-2018. MMWR Morb Mortal Wkly Rep 2020; 69:390.</a></li><li class="breakAll">Centers for Disease Control and Prevention: Adult obesity facts. Available at: https://www.cdc.gov/obesity/data/adult.html (Accessed on January 24, 2023).</li><li><a class="nounderline abstract_t">Zeller MH, Roehrig HR, Modi AC, et al. Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery. Pediatrics 2006; 117:1155.</a></li><li><a class="nounderline abstract_t">Xanthakos SA, Jenkins TM, Kleiner DE, et al. High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology 2015; 149:623.</a></li><li><a class="nounderline abstract_t">Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis 2018; 14:882.</a></li><li><a class="nounderline abstract_t">Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr 2017; 88:371.</a></li><li><a class="nounderline abstract_t">Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics 2023; 151.</a></li><li><a class="nounderline abstract_t">Skinner AC, Staiano AE, Armstrong SC, et al. Appraisal of Clinical Care Practices for Child Obesity Treatment. Part II: Comorbidities. Pediatrics 2023; 151.</a></li><li><a class="nounderline abstract_t">Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med 2014; 11:e1001673.</a></li><li><a class="nounderline abstract_t">Sarno LA, Lipshultz SE, Harmon C, et al. Short- and long-term safety and efficacy of bariatric surgery for severely obese adolescents: a narrative review. Pediatr Res 2020; 87:202.</a></li><li><a class="nounderline abstract_t">Weihrauch-Blüher S, Schwarz P, Klusmann JH. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism 2019; 92:147.</a></li><li><a class="nounderline abstract_t">Carlsson LMS, Sjöholm K, Jacobson P, et al. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med 2020; 383:1535.</a></li><li><a class="nounderline abstract_t">Armstrong SC, Bolling CF, Michalsky MP, et al. Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Skinner AC, Ravanbakht SN, Skelton JA, et al. Prevalence of Obesity and Severe Obesity in US Children, 1999-2016. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Freedman DS, Mei Z, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 2007; 150:12.</a></li><li><a class="nounderline abstract_t">Skelton JA, Cook SR, Auinger P, et al. Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 2009; 9:322.</a></li><li><a class="nounderline abstract_t">Bibbins-Domingo K, Coxson P, Pletcher MJ, et al. Adolescent overweight and future adult coronary heart disease. N Engl J Med 2007; 357:2371.</a></li><li><a class="nounderline abstract_t">Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327:1350.</a></li><li><a class="nounderline abstract_t">Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357:2329.</a></li><li><a class="nounderline abstract_t">Must A, Phillips SM, Naumova EN. Occurrence and timing of childhood overweight and mortality: findings from the Third Harvard Growth Study. J Pediatr 2012; 160:743.</a></li><li><a class="nounderline abstract_t">Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic Risks and Severity of Obesity in Children and Young Adults. N Engl J Med 2015; 373:1307.</a></li><li><a class="nounderline abstract_t">Berkowitz RI, Fujioka K, Daniels SR, et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006; 145:81.</a></li><li><a class="nounderline abstract_t">Chanoine JP, Hampl S, Jensen C, et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005; 293:2873.</a></li><li><a class="nounderline abstract_t">Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol 2017; 5:174.</a></li><li><a class="nounderline abstract_t">Reames BN, Finks JF, Bacal D, et al. Changes in bariatric surgery procedure use in Michigan, 2006-2013. JAMA 2014; 312:959.</a></li><li><a class="nounderline abstract_t">Inge TH, Zeller MH, Jenkins TM, et al. Perioperative outcomes of adolescents undergoing bariatric surgery: the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study. JAMA Pediatr 2014; 168:47.</a></li><li><a class="nounderline abstract_t">Steinberger AE, Nickel KB, Keller M, et al. National Trends in Pediatric Metabolic and Bariatric Surgery: 2010-2017. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Inge TH, Coley RY, Bazzano LA, et al. Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study. Surg Obes Relat Dis 2018; 14:1374.</a></li><li><a class="nounderline abstract_t">Jackson WL, Lewis SR, Bagby JP, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass in the pediatric population: a MBSAQIP analysis. Surg Obes Relat Dis 2020; 16:254.</a></li><li><a class="nounderline abstract_t">Howard R, Yang J, Thumma J, et al. Health Care Use and Adverse Events After Sleeve Gastrectomy and Gastric Bypass Among Adolescents With Severe Obesity Insured by Medicaid. JAMA 2022; 328:1972.</a></li><li><a class="nounderline abstract_t">Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 2010; 6:1.</a></li><li><a class="nounderline abstract_t">Paulus GF, de Vaan LE, Verdam FJ, et al. Bariatric surgery in morbidly obese adolescents: a systematic review and meta-analysis. Obes Surg 2015; 25:860.</a></li><li><a class="nounderline abstract_t">Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 2009; 123:214.</a></li><li><a class="nounderline abstract_t">Sachdev P, Reece L, Thomson M, et al. Intragastric balloon as an adjunct to lifestyle programme in severely obese adolescents: impact on biomedical outcomes and skeletal health. Int J Obes (Lond) 2018; 42:115.</a></li><li><a class="nounderline abstract_t">Kelly AS, Barlow SE, Rao G, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation 2013; 128:1689.</a></li><li><a class="nounderline abstract_t">Chan JL, Mun EC, Stoyneva V, et al. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 2006; 14:194.</a></li><li><a class="nounderline abstract_t">Korner J, Bessler M, Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90:359.</a></li><li><a class="nounderline abstract_t">Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006; 14:1553.</a></li><li><a class="nounderline abstract_t">le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243:108.</a></li><li><a class="nounderline abstract_t">Alvarez Bartolomé M, Borque M, Martinez-Sarmiento J, et al. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg 2002; 12:324.</a></li><li><a class="nounderline abstract_t">Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509:183.</a></li><li><a class="nounderline abstract_t">Kohli R, Bradley D, Setchell KD, et al. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 2013; 98:E708.</a></li><li><a class="nounderline abstract_t">Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013; 21:E660.</a></li><li><a class="nounderline abstract_t">Khan FH, Shaw L, Zhang W, et al. Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents. Obesity (Silver Spring) 2016; 24:2377.</a></li><li><a class="nounderline abstract_t">Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004; 114:217.</a></li><li><a class="nounderline abstract_t">Apovian CM, Baker C, Ludwig DS, et al. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005; 13:274.</a></li><li><a class="nounderline abstract_t">Styne DM, Arslanian SA, Connor EL, et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102:709.</a></li><li><a class="nounderline abstract_t">Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring) 2009; 17:901.</a></li><li><a class="nounderline abstract_t">Michalsky M, Reichard K, Inge T, et al. ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis 2012; 8:1.</a></li><li><a class="nounderline abstract_t">Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis 2022; 18:1345.</a></li><li><a class="nounderline abstract_t">Alqahtani A, Elahmedi M, Qahtani AR. Laparoscopic Sleeve Gastrectomy in Children Younger Than 14 Years: Refuting the Concerns. Ann Surg 2016; 263:312.</a></li><li><a class="nounderline abstract_t">O'Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 2010; 303:519.</a></li><li><a class="nounderline abstract_t">Torbahn G, Brauchmann J, Axon E, et al. Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev 2022; 9:CD011740.</a></li><li><a class="nounderline abstract_t">Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577.</a></li><li><a class="nounderline abstract_t">Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366:1567.</a></li><li><a class="nounderline abstract_t">Inge TH, Jenkins TM, Xanthakos SA, et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol 2017; 5:165.</a></li><li><a class="nounderline abstract_t">Ogle SB, Dewberry LC, Jenkins TM, et al. Outcomes of Bariatric Surgery in Older Versus Younger Adolescents. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Shah AS, D'Alessio D, Ford-Adams ME, et al. Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth. Diabetes Care 2016; 39:934.</a></li><li><a class="nounderline abstract_t">Khidir N, El-Matbouly MA, Sargsyan D, et al. Five-year Outcomes of Laparoscopic Sleeve Gastrectomy: a Comparison Between Adults and Adolescents. Obes Surg 2018; 28:2040.</a></li><li><a class="nounderline abstract_t">Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond) 2007; 31:1.</a></li><li><a class="nounderline abstract_t">Stefater MA, Inge TH. Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy. Curr Diab Rep 2017; 17:62.</a></li><li><a class="nounderline abstract_t">Hornack SE, Nadler EP, Wang J, et al. Sleeve Gastrectomy for Youth With Cognitive Impairment or Developmental Disability. Pediatrics 2019; 143.</a></li><li><a class="nounderline abstract_t">Goddard GR, Kotagal M, Jenkins TM, et al. Weight loss after sleeve gastrectomy in developmentally delayed adolescents and young adults. Surg Obes Relat Dis 2019; 15:1662.</a></li><li><a class="nounderline abstract_t">Alqahtani AR, Antonisamy B, Alamri H, et al. Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years. Ann Surg 2012; 256:266.</a></li><li><a class="nounderline abstract_t">Alqahtani AR, Elahmedi MO, Al Qahtani A. Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy. Surg Obes Relat Dis 2014; 10:842.</a></li><li><a class="nounderline abstract_t">Alqahtani AR, Elahmedi MO, Al Qahtani AR, et al. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study. Surg Obes Relat Dis 2016; 12:100.</a></li><li><a class="nounderline abstract_t">Scheimann AO, Butler MG, Gourash L, et al. Critical analysis of bariatric procedures in Prader-Willi syndrome. J Pediatr Gastroenterol Nutr 2008; 46:80.</a></li><li><a class="nounderline abstract_t">Inge TH. A new look at weight loss surgery for children and adolescents with Prader-Willi syndrome. Surg Obes Relat Dis 2016; 12:110.</a></li><li><a class="nounderline abstract_t">Rose SR, Horne VE, Bingham N, et al. Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders. Obesity (Silver Spring) 2018; 26:1727.</a></li><li><a class="nounderline abstract_t">Weismann D, Pelka T, Bender G, et al. Bariatric surgery for morbid obesity in craniopharyngioma. Clin Endocrinol (Oxf) 2013; 78:385.</a></li><li><a class="nounderline abstract_t">Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, et al. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up. Int J Obes (Lond) 2017; 41:210.</a></li><li><a class="nounderline abstract_t">Bretault M, Boillot A, Muzard L, et al. Clinical review: Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab 2013; 98:2239.</a></li><li><a class="nounderline abstract_t">Inge TH, Donnelly LF, Vierra M, et al. Managing bariatric patients in a children's hospital: radiologic considerations and limitations. J Pediatr Surg 2005; 40:609.</a></li><li><a class="nounderline abstract_t">American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 2013; 9:493.</a></li><li><a class="nounderline abstract_t">Cummins CB, Nunez Lopez O, Hughes BD, et al. Adolescent Bariatric Surgery: Effects of Socioeconomic, Demographic, and Hospital Characteristics on Cost, Length of Stay, and Type of Procedure Performed. Obes Surg 2019; 29:757.</a></li><li><a class="nounderline abstract_t">Kyler KE, Bettenhausen JL, Hall M, et al. Trends in Volume and Utilization Outcomes in Adolescent Metabolic and Bariatric Surgery at Children's Hospitals. J Adolesc Health 2019; 65:331.</a></li><li><a class="nounderline abstract_t">Fullmer MA, Abrams SH, Hrovat K, et al. Nutritional strategy for adolescents undergoing bariatric surgery: report of a working group of the Nutrition Committee of NASPGHAN/NACHRI. J Pediatr Gastroenterol Nutr 2012; 54:125.</a></li><li><a class="nounderline abstract_t">Armstrong-Javors A, Pratt J, Kharasch S. Wernicke Encephalopathy in Adolescents After Bariatric Surgery: Case Report and Review. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Towbin A, Inge TH, Garcia VF, et al. Beriberi after gastric bypass surgery in adolescence. J Pediatr 2004; 145:263.</a></li><li><a class="nounderline abstract_t">Ibrahim T, El Ansari W, Abusabeib A, et al. Infrequent but serious? Beriberi And Thiamine deficiency among adolescents and young adults after bariatric surgery. Surg Obes Relat Dis 2023.</a></li><li><a class="nounderline abstract_t">Goldschmidt AB, Khoury J, Jenkins TM, et al. Adolescent Loss-of-Control Eating and Weight Loss Maintenance After Bariatric Surgery. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg 2006; 16:1457.</a></li><li><a class="nounderline abstract_t">Escobar-Morreale HF, Santacruz E, Luque-Ramírez M, Botella Carretero JI. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update 2017; 23:390.</a></li><li><a class="nounderline abstract_t">Roehrig HR, Xanthakos SA, Sweeney J, et al. Pregnancy after gastric bypass surgery in adolescents. Obes Surg 2007; 17:873.</a></li><li><a class="nounderline abstract_t">Holt VL, Cushing-Haugen KL, Daling JR. Body weight and risk of oral contraceptive failure. Obstet Gynecol 2002; 99:820.</a></li><li><a class="nounderline abstract_t">Holt VL, Scholes D, Wicklund KG, et al. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005; 105:46.</a></li><li><a class="nounderline abstract_t">Zieman M, Guillebaud J, Weisberg E, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002; 77:S13.</a></li><li><a class="nounderline abstract_t">Mangan SA, Larsen PG, Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 2002; 15:79.</a></li><li><a class="nounderline abstract_t">Bonny AE, Ziegler J, Harvey R, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006; 160:40.</a></li><li><a class="nounderline abstract_t">Luukkainen T, Lähteenmäki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 1990; 22:85.</a></li><li><a class="nounderline abstract_t">Miller RJ, Xanthakos SA, Hillard PJ, Inge TH. Bariatric surgery and adolescent gynecology. Curr Opin Obstet Gynecol 2007; 19:427.</a></li><li><a class="nounderline abstract_t">Woodard CB. Pregnancy following bariatric surgery. J Perinat Neonatal Nurs 2004; 18:329.</a></li><li><a class="nounderline abstract_t">McPhee J, Khlyavich Freidl E, Eicher J, et al. Suicidal Ideation and Behaviours Among Adolescents Receiving Bariatric Surgery: A Case-Control Study. Eur Eat Disord Rev 2015; 23:517.</a></li><li><a class="nounderline abstract_t">Castaneda D, Popov VB, Wander P, Thompson CC. Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis. Obes Surg 2019; 29:322.</a></li><li><a class="nounderline abstract_t">Duffecy J, Bleil ME, Labott SM, et al. Psychopathology in adolescents presenting for laparoscopic banding. J Adolesc Health 2008; 43:623.</a></li><li><a class="nounderline abstract_t">Järvholm K, Karlsson J, Olbers T, et al. Characteristics of adolescents with poor mental health after bariatric surgery. Surg Obes Relat Dis 2016; 12:882.</a></li><li><a class="nounderline abstract_t">Zeller MH, Reiter-Purtill J, Jenkins TM, et al. Suicidal thoughts and behaviors in adolescents who underwent bariatric surgery. Surg Obes Relat Dis 2020; 16:568.</a></li><li class="breakAll">Miech RA, Schulenberg JE, Johnston LD, et al. Monitoring the Future: A Continuing Study of American Youth. 2019. Available at: http://www.monitoringthefuture.org (Accessed on December 19, 2019).</li><li class="breakAll">Inge TH. Unpublished observations from the Teen-LABS study, 2019.</li><li><a class="nounderline abstract_t">Inge TH, Courcoulas AP, Jenkins TM, et al. Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med 2016; 374:113.</a></li><li><a class="nounderline abstract_t">Järvholm K, Janson A, Peltonen M, et al. Metabolic and bariatric surgery versus intensive non-surgical treatment for adolescents with severe obesity (AMOS2): a multicentre, randomised, controlled trial in Sweden. Lancet Child Adolesc Health 2023; 7:249.</a></li><li><a class="nounderline abstract_t">Boza C, Viscido G, Salinas J, et al. Laparoscopic sleeve gastrectomy in obese adolescents: results in 51 patients. Surg Obes Relat Dis 2012; 8:133.</a></li><li><a class="nounderline abstract_t">Strauss RS, Bradley LJ, Brolin RE. Gastric bypass surgery in adolescents with morbid obesity. J Pediatr 2001; 138:499.</a></li><li><a class="nounderline abstract_t">Sugerman HJ, Sugerman EL, DeMaria EJ, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003; 7:102.</a></li><li><a class="nounderline abstract_t">Olbers T, Gronowitz E, Werling M, et al. Two-year outcome of laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity: results from a Swedish Nationwide Study (AMOS). Int J Obes (Lond) 2012; 36:1388.</a></li><li><a class="nounderline abstract_t">Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg 2008; 248:763.</a></li><li><a class="nounderline abstract_t">de la Cruz-Muñoz N, Xie L, Quiroz HJ, et al. Long-Term Outcomes after Adolescent Bariatric Surgery. J Am Coll Surg 2022; 235:592.</a></li><li><a class="nounderline abstract_t">Messiah SE, Lopez-Mitnik G, Winegar D, et al. Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2013; 9:503.</a></li><li><a class="nounderline abstract_t">Al-Qahtani AR. Laparoscopic adjustable gastric banding in adolescent: safety and efficacy. J Pediatr Surg 2007; 42:894.</a></li><li><a class="nounderline abstract_t">Dillard BE 3rd, Gorodner V, Galvani C, et al. Initial experience with the adjustable gastric band in morbidly obese US adolescents and recommendations for further investigation. J Pediatr Gastroenterol Nutr 2007; 45:240.</a></li><li><a class="nounderline abstract_t">Nadler EP, Youn HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg 2008; 43:141.</a></li><li><a class="nounderline abstract_t">Fielding GA, Duncombe JE. Laparoscopic adjustable gastric banding in severely obese adolescents. Surg Obes Relat Dis 2005; 1:399.</a></li><li><a class="nounderline abstract_t">Holterman AX, Browne A, Tussing L, et al. A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes. J Pediatr Surg 2010; 45:74.</a></li><li><a class="nounderline abstract_t">Pedroso FE, Angriman F, Endo A, et al. Weight loss after bariatric surgery in obese adolescents: a systematic review and meta-analysis. Surg Obes Relat Dis 2018; 14:413.</a></li><li><a class="nounderline abstract_t">Norain A, Arafat M, Burjonrappa S. Trending Weight Loss Patterns in Obese and Super Obese Adolescents: Does Laparoscopic Sleeve Gastrectomy Provide Equivalent Outcomes in both Groups? Obes Surg 2019; 29:2511.</a></li><li><a class="nounderline abstract_t">Inge TH, Jenkins TM, Zeller M, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr 2010; 156:103.</a></li><li><a class="nounderline abstract_t">Rand CS, Macgregor AM. Adolescents having obesity surgery: a 6-year follow-up. South Med J 1994; 87:1208.</a></li><li><a class="nounderline abstract_t">van Mil SR, Biter LU, Grotenhuis BA, et al. Laparoscopic Sleeve Gastrectomy versus Gastric Bypass in Late Adolescents: What Is the Optimal Surgical Strategy for Morbid Obesity? Eur J Pediatr Surg 2016; 26:487.</a></li><li><a class="nounderline abstract_t">Shoar S, Mahmoudzadeh H, Naderan M, et al. Long-Term Outcome of Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-Analysis of 950 Patients with a Minimum of 3 years Follow-Up. Obes Surg 2017; 27:3110.</a></li><li><a class="nounderline abstract_t">Cozacov Y, Roy M, Moon S, et al. Mid-term results of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass in adolescent patients. Obes Surg 2014; 24:747.</a></li><li><a class="nounderline abstract_t">Black JA, White B, Viner RM, Simmons RK. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev 2013; 14:634.</a></li><li><a class="nounderline abstract_t">Kalra M, Inge T, Garcia V, et al. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res 2005; 13:1175.</a></li><li><a class="nounderline abstract_t">Lawson ML, Kirk S, Mitchell T, et al. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006; 41:137.</a></li><li><a class="nounderline abstract_t">Loux TJ, Haricharan RN, Clements RH, et al. Health-related quality of life before and after bariatric surgery in adolescents. J Pediatr Surg 2008; 43:1275.</a></li><li><a class="nounderline abstract_t">Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009; 137:532.</a></li><li><a class="nounderline abstract_t">Loy JJ, Youn HA, Schwack B, et al. Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery. Surg Obes Relat Dis 2015; 11:442.</a></li><li><a class="nounderline abstract_t">Corey KE, Vuppalanchi R, Vos M, et al. Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2015; 60:360.</a></li><li><a class="nounderline abstract_t">Inge TH, Prigeon RL, Elder DA, et al. Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents. J Pediatr 2015; 167:1042.</a></li><li><a class="nounderline abstract_t">Manco M, Mosca A, De Peppo F, et al. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis. J Pediatr 2017; 180:31.</a></li><li class="breakAll">Inge TH, Laffel L, Jenkins T, et al. Surgical therapy is more effective than medical therapy in the treatment of type 2 diabetes (T2D) in severely obese adolescents. (Meeting Abstract, #159-LB). Available at: http://diabetes.diabetesjournals.org/content/diabetes/suppl/2016/06/20/65.Supplement_1.DC1/2016_ADA_LB_Abstracts_HiRes_FINAL_5_11_16.pdf (Accessed on February 11, 2017).</li><li><a class="nounderline abstract_t">Michalsky MP, Inge TH, Jenkins TM, et al. Cardiovascular Risk Factors After Adolescent Bariatric Surgery. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Dhindsa S, Ghanim H, Jenkins T, et al. High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery. Eur J Endocrinol 2022; 186:319.</a></li><li><a class="nounderline abstract_t">Inge T, Wilson KA, Gamm K, et al. Preferential loss of central (trunk) adiposity in adolescents and young adults after laparoscopic gastric bypass. Surg Obes Relat Dis 2007; 3:153.</a></li><li><a class="nounderline abstract_t">Ippisch HM, Inge TH, Daniels SR, et al. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol 2008; 51:1342.</a></li><li><a class="nounderline abstract_t">Inge TH, Courcoulas AP, Jenkins TM, et al. Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults. N Engl J Med 2019; 380:2136.</a></li><li><a class="nounderline abstract_t">Nehus EJ, Khoury JC, Inge TH, et al. Kidney outcomes three years after bariatric surgery in severely obese adolescents. Kidney Int 2017; 91:451.</a></li><li><a class="nounderline abstract_t">Ryder JR, Edwards NM, Gupta R, et al. Changes in Functional Mobility and Musculoskeletal Pain After Bariatric Surgery in Teens With Severe Obesity: Teen-Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Pediatr 2016; 170:871.</a></li><li><a class="nounderline abstract_t">Bout-Tabaku S, Gupta R, Jenkins TM, et al. Musculoskeletal Pain, Physical Function, and Quality of Life After Bariatric Surgery. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Järvholm K, Olbers T, Marcus C, et al. Short-term psychological outcomes in severely obese adolescents after bariatric surgery. Obesity (Silver Spring) 2012; 20:318.</a></li><li><a class="nounderline abstract_t">Zeller MH, Reiter-Purtill J, Ratcliff MB, et al. Two-year trends in psychosocial functioning after adolescent Roux-en-Y gastric bypass. Surg Obes Relat Dis 2011; 7:727.</a></li><li><a class="nounderline abstract_t">Hunsaker SL, Garland BH, Rofey D, et al. A Multisite 2-Year Follow Up of Psychopathology Prevalence, Predictors, and Correlates Among Adolescents Who Did or Did Not Undergo Weight Loss Surgery. J Adolesc Health 2018; 63:142.</a></li><li><a class="nounderline abstract_t">Altieri MS, Pryor A, Bates A, et al. Bariatric procedures in adolescents are safe in accredited centers. Surg Obes Relat Dis 2018; 14:1368.</a></li><li><a class="nounderline abstract_t">Tsai WS, Inge TH, Burd RS. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med 2007; 161:217.</a></li><li><a class="nounderline abstract_t">Varela JE, Hinojosa MW, Nguyen NT. Perioperative outcomes of bariatric surgery in adolescents compared with adults at academic medical centers. Surg Obes Relat Dis 2007; 3:537.</a></li><li><a class="nounderline abstract_t">Xanthakos SA, Khoury JC, Inge TH, et al. Nutritional Risks in Adolescents After Bariatric Surgery. Clin Gastroenterol Hepatol 2020; 18:1070.</a></li><li><a class="nounderline abstract_t">Lindeman KG, Rushin CC, Cheney MC, et al. Bone Density and Trabecular Morphology at Least 10 Years After Gastric Bypass and Gastric Banding. J Bone Miner Res 2020; 35:2132.</a></li><li><a class="nounderline abstract_t">Saad RK, Ghezzawi M, Habli D, et al. Fracture risk following bariatric surgery: a systematic review and meta-analysis. Osteoporos Int 2022; 33:511.</a></li><li><a class="nounderline abstract_t">Kaulfers AM, Bean JA, Inge TH, et al. Bone loss in adolescents after bariatric surgery. Pediatrics 2011; 127:e956.</a></li><li><a class="nounderline abstract_t">Beamish AJ, Gronowitz E, Olbers T, et al. Body composition and bone health in adolescents after Roux-en-Y gastric bypass for severe obesity. Pediatr Obes 2017; 12:239.</a></li><li><a class="nounderline abstract_t">Misra M, Singhal V, Carmine B, et al. Bone outcomes following sleeve gastrectomy in adolescents and young adults with obesity versus non-surgical controls. Bone 2020; 134:115290.</a></li><li><a class="nounderline abstract_t">Huber FA, Singhal V, Tuli S, et al. Two-year Skeletal Effects of Sleeve Gastrectomy in Adolescents with Obesity Assessed with Quantitative CT and MR Spectroscopy. Radiology 2023; 307:e223256.</a></li><li><a class="nounderline abstract_t">Muschitz C, Kocijan R, Haschka J, et al. The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study. J Bone Miner Res 2016; 31:672.</a></li><li><a class="nounderline abstract_t">Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005; 48:2236.</a></li><li><a class="nounderline abstract_t">Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353:249.</a></li><li><a class="nounderline abstract_t">Papamargaritis D, Koukoulis G, Sioka E, et al. Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy. Obes Surg 2012; 22:1600.</a></li><li><a class="nounderline abstract_t">Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92:4678.</a></li><li><a class="nounderline abstract_t">Eisenberg D, Azagury DE, Ghiassi S, et al. ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery. Surg Obes Relat Dis 2017; 13:371.</a></li><li><a class="nounderline abstract_t">Dewberry LC, Khoury JC, Ehrlich S, et al. Change in gastrointestinal symptoms over the first 5 years after bariatric surgery in a multicenter cohort of adolescents. J Pediatr Surg 2019; 54:1220.</a></li><li><a class="nounderline abstract_t">White GE, Boles RE, Courcoulas AP, et al. A Prospective Cohort of Alcohol Use and Alcohol-related Problems Before and After Metabolic and Bariatric Surgery in Adolescents. Ann Surg 2023; 278:e519.</a></li><li><a class="nounderline abstract_t">Dang JT, Vaughan T, Mocanu V, et al. Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Indications, Prevalence, and Safety. Obes Surg 2023; 33:1486.</a></li></ol></div><div id="topicVersionRevision">Topic 5880 Version 66.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27115820" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32240130" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : QuickStats: Prevalence of Obesity* and Severe Obesity†Among Persons Aged 2-19 Years - National Health and Nutrition Examination Survey, 1999-2000 through 2017-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32240130" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : QuickStats: Prevalence of Obesity* and Severe Obesity†Among Persons Aged 2-19 Years - National Health and Nutrition Examination Survey, 1999-2000 through 2017-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16585310" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26026390" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30077361" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29156452" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36622115" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36622098" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Appraisal of Clinical Care Practices for Child Obesity Treatment. Part II: Comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25003901" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31401646" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Short- and long-term safety and efficacy of bariatric surgery for severely obese adolescents: a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30529454" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33053284" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31656225" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29483202" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevalence of Obesity and Severe Obesity in US Children, 1999-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17188605" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19560993" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Prevalence and trends of severe obesity among US children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18057339" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Adolescent overweight and future adult coronary heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1406836" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18057335" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Childhood body-mass index and the risk of coronary heart disease in adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22183448" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Occurrence and timing of childhood overweight and mortality: findings from the Third Harvard Growth Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26422721" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cardiometabolic Risks and Severity of Obesity in Children and Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16847290" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effects of sibutramine treatment in obese adolescents: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15956632" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28065734" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25182106" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Changes in bariatric surgery procedure use in Michigan, 2006-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24189578" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Perioperative outcomes of adolescents undergoing bariatric surgery: the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36373280" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : National Trends in Pediatric Metabolic and Bariatric Surgery: 2010-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29793877" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31843455" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass in the pediatric population: a MBSAQIP analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36378216" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Health Care Use and Adverse Events After Sleeve Gastrectomy and Gastric Bypass Among Adolescents With Severe Obesity Insured by Medicaid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19939744" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Updated position statement on sleeve gastrectomy as a bariatric procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25697125" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Bariatric surgery in morbidly obese adolescents: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19117885" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28871150" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Intragastric balloon as an adjunct to lifestyle programme in severely obese adolescents: impact on biomedical outcomes and skeletal health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24016455" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16571843" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Peptide YY levels are elevated after gastric bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15483088" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17030966" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371744" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12082881" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24670636" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : FXR is a molecular target for the effects of vertical sleeve gastrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23457410" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23804517" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27615057" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15231931" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Bariatric surgery for severely overweight adolescents: concerns and recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15800284" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Best practice guidelines in pediatric/adolescent weight loss surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28359099" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19396070" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Best practice updates for pediatric/adolescent weight loss surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22030146" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : ASMBS pediatric committee best practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36280539" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26496081" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Laparoscopic Sleeve Gastrectomy in Children Younger Than 14 Years: Refuting the Concerns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20145228" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36074911" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Surgery for the treatment of obesity in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22449317" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bariatric surgery versus conventional medical therapy for type 2 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22449319" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Bariatric surgery versus intensive medical therapy in obese patients with diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28065736" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33526606" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Outcomes of Bariatric Surgery in Older Versus Younger Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27222551" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29430596" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Five-year Outcomes of Laparoscopic Sleeve Gastrectomy: a Comparison Between Adults and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17173060" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Bariatric surgery for pediatric extreme obesity: now or later?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28681327" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30988024" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Sleeve Gastrectomy for Youth With Cognitive Impairment or Developmental Disability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31522981" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Weight loss after sleeve gastrectomy in developmentally delayed adolescents and young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22504281" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25439000" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26431633" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18162838" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Critical analysis of bariatric procedures in Prader-Willi syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26507938" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : A new look at weight loss surgery for children and adolescents with Prader-Willi syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30296362" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22506774" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Bariatric surgery for morbid obesity in craniopharyngioma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27795552" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23533238" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Clinical review: Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15852267" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Managing bariatric patients in a children's hospital: radiologic considerations and limitations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23769113" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30612326" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Adolescent Bariatric Surgery: Effects of Socioeconomic, Demographic, and Hospital Characteristics on Cost, Length of Stay, and Type of Procedure Performed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31196785" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Trends in Volume and Utilization Outcomes in Adolescent Metabolic and Bariatric Surgery at Children's Hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21857247" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Nutritional strategy for adolescents undergoing bariatric surgery: report of a working group of the Nutrition Committee of NASPGHAN/NACHRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940680" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Wernicke Encephalopathy in Adolescents After Bariatric Surgery: Case Report and Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15289782" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Beriberi after gastric bypass surgery in adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37620168" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Infrequent but serious? Beriberi And Thiamine deficiency among adolescents and young adults after bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29237801" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Adolescent Loss-of-Control Eating and Weight Loss Maintenance After Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17132411" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The impact of bariatric surgery on menstrual patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28486593" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17894144" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Pregnancy after gastric bypass surgery in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11978293" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Body weight and risk of oral contraceptive failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15625141" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Body mass index, weight, and oral contraceptive failure risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11849631" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12057528" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16389209" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2113816" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Levonorgestrel-releasing intrauterine device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17885457" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Bariatric surgery and adolescent gynecology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15646304" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Pregnancy following bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26377705" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Suicidal Ideation and Behaviours Among Adolescents Receiving Bariatric Surgery: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30343409" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19027654" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Psychopathology in adolescents presenting for laparoscopic banding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27134198" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Characteristics of adolescents with poor mental health after bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32035828" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Suicidal thoughts and behaviors in adolescents who underwent bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32035828" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Suicidal thoughts and behaviors in adolescents who underwent bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32035828" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Suicidal thoughts and behaviors in adolescents who underwent bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26544725" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36848922" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Metabolic and bariatric surgery versus intensive non-surgical treatment for adolescents with severe obesity (AMOS2): a multicentre, randomised, controlled trial in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22433934" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Laparoscopic sleeve gastrectomy in obese adolescents: results in 51 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11295712" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Gastric bypass surgery in adolescents with morbid obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12559191" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Bariatric surgery for severely obese adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23007037" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Two-year outcome of laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity: results from a Swedish Nationwide Study (AMOS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18948803" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Systematic review and meta-analysis of bariatric surgery for pediatric obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36102560" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Long-Term Outcomes after Adolescent Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22542199" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17502207" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Laparoscopic adjustable gastric banding in adolescent: safety and efficacy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17667722" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Initial experience with the adjustable gastric band in morbidly obese US adolescents and recommendations for further investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18206472" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16925257" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Laparoscopic adjustable gastric banding in severely obese adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20105583" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29248351" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Weight loss after bariatric surgery in obese adolescents: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31044352" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Trending Weight Loss Patterns in Obese and Super Obese Adolescents: Does Laparoscopic Sleeve Gastrectomy Provide Equivalent Outcomes in both Groups?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19775700" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7973919" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Adolescents having obesity surgery: a 6-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26745522" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Laparoscopic Sleeve Gastrectomy versus Gastric Bypass in Late Adolescents: What Is the Optimal Surgical Strategy for Morbid Obesity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28573535" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Long-Term Outcome of Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-Analysis of 950 Patients with a Minimum of 3 years Follow-Up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24390732" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Mid-term results of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass in adolescent patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23577666" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16076986" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16410123" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18639682" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Health-related quality of life before and after bariatric surgery in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19409898" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25820083" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25714579" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26363548" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Insulin Sensitivity andβ-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27697327" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27697327" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29311357" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Cardiovascular Risk Factors After Adolescent Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35007209" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17386396" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Preferential loss of central (trunk) adiposity in adolescents and young adults after laparoscopic gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18387434" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Reversibility of cardiac abnormalities in morbidly obese adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31116917" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27914704" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Kidney outcomes three years after bariatric surgery in severely obese adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27429076" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Changes in Functional Mobility and Musculoskeletal Pain After Bariatric Surgery in Teens With Severe Obesity: Teen-Longitudinal Assessment of Bariatric Surgery (LABS) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31744891" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Musculoskeletal Pain, Physical Function, and Quality of Life After Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21996668" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Short-term psychological outcomes in severely obese adolescents after bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21497142" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Two-year trends in psychosocial functioning after adolescent Roux-en-Y gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29724670" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : A Multisite 2-Year Follow Up of Psychopathology Prevalence, Predictors, and Correlates Among Adolescents Who Did or Did Not Undergo Weight Loss Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29980465" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Bariatric procedures in adolescents are safe in accredited centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17339501" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17903775" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Perioperative outcomes of bariatric surgery in adolescents compared with adults at academic medical centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31706057" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Nutritional Risks in Adolescents After Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32663365" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Bone Density and Trabecular Morphology at Least 10 Years After Gastric Bypass and Gastric Banding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34988627" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Fracture risk following bariatric surgery: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21444596" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Bone loss in adolescents after bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27071497" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Body composition and bone health in adolescents after Roux-en-Y gastric bypass for severe obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32084562" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Bone outcomes following sleeve gastrectomy in adolescents and young adults with obesity versus non-surgical controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37310246" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Two-year Skeletal Effects of Sleeve Gastrectomy in Adolescents with Obesity Assessed with Quantitative CT and MR Spectroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26350034" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16195867" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034010" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22773085" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17895322" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28110984" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30879757" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Change in gastrointestinal symptoms over the first 5 years after bariatric surgery in a multicenter cohort of adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36538630" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : A Prospective Cohort of Alcohol Use and Alcohol-related Problems Before and After Metabolic and Bariatric Surgery in Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36922465" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Indications, Prevalence, and Safety.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
